Entering the fourth quarter, pharmaceutical equipment industry enterprises have what actions?

"Pharmaceutical Network Market Analysis" into the fourth quarter, with the third batch of results in various places to promote the landing, as well as consistent evaluation, new health insurance negotiations and other policies, pharmaceutical companies for cost control, capacity upgrading and other aspects of new demand and new requirements will be more obvious, the industry expects the domestic pharmaceutical equipment industry will usher in growth.
so in this context, pharmaceutical equipment industry enterprises have what action? The author combs this briefly.
Pharmaceutical Equipment (Photo: Pharmaceutical Network) revealed that the third-quarter report of the 2020 listed company's third-quarter report revealed the curtain opened after the double festival.
in the pharmaceutical equipment industry, Dongfulong has recently disclosed its first three quarters of 2020 earnings forecast, the company's first three quarters of 2020 net profit of 279 million to 297 million.
new products and new markets in various sectors of its business over the years have gradually shown results, and net profit attributable to shareholders of listed companies is expected to increase by 360%-390% year-on-year.
Is an integrated pharmaceutical equipment service provider that provides pharmaceutical processes, core equipment and systems engineering solutions to pharmaceutical companies worldwide.
personnel changes into October, in the major listed companies have disclosed performance data at the same time, some of the company's management also ushered in some major personnel changes.
Chutian Technology announced on the evening of October 20 that the company's board of directors had recently received a resignation report from Mr. Zhou Jiangjun, the company's director.
Zhou Jiangjun applied to resign as a director of the company's fourth board of directors for personal reasons.
Mr. Zhou Jiangjun no longer held any position in the company.
that his departure will not affect the normal development of the company's related work, the company will complete the by-election of directors in a timely manner in accordance with the statutory procedures.
as of this announcement, Mr. Zhou Jiangjun does not directly hold shares in the company.
the construction of orderly projects since this year, including Chutian, Canaan science and technology, including a number of pharmaceutical companies are promoting the construction of new projects, from the current progress, some companies are still in an orderly progress in the construction.
October 19 news, some investors to Canaan Technology asked: "According to the company's prior announcement, the implementation of this non-public project site in the north of the street land has been signed and paid for the plot, please ask the company this non-public project has used liquidity for the early investment?" How's it going? In response, the company said that the company in strict accordance with the requirements and its own development plans to promote the construction projects in an orderly manner related planning approval and follow-up construction.
understand that the project can be traced back to the company's announcement on the evening of September 8, when the company said it plans to raise no more than 450 million yuan (including this number) to expand the layout of innovative business areas.
Among them, it is proposed to invest in a new intelligent logistics system production center in The New Area of Weibei City, Wenzhou City, Zhejiang Province, with a total investment of 203 million yuan, with a total investment of 180 million yuan to be invested and a construction period of two years.
said that the smooth implementation of the project will expand the company's intelligent logistics system capacity, in line with the downstream industry trends, to better meet market demand.
unique, Xinma Pharmaceutical Equipment Co., Ltd. is also promoting high-end pharmaceutical equipment industrialization project, the launch of the project marks a further upgrade of Xinma Pharmaceutical's technological innovation.
project will be put into operation by the end of this year.
is expected to be completed and put into operation after sales revenue of 1.2 billion yuan, annual profits of 180 million yuan, annual tax of 52 million yuan, 500 new employment.
actively participate in the first half of the exhibition by the impact of the special period, many exhibitions were forced to cancel, with the domestic related prevention and control gradually perfected, the second half of the exhibition is a good time for enterprises to show their style.
For example, at the 85th China International Pharmaceutical Equipment Exhibition (API China) held in Nanjing from October 14th to October 16th, thousands of exhibitors participated in the exhibition, including Corning Pharmaceutical Technology, Peller Health, Shanghai Jieyu, Zhejiang Yuma, Parkway, Vida Machinery, Guanghua Packaging Machinery, Ningbo Xinyuan, Format, Great Wall Science, Industry and Trade, Corning and many other enterprises shine on the scene, big show new products, new technologies, new programs, with the scene of exhibitors, audience exchanges and cooperation, to share the great market opportunities brought about by the vigorous development of China's large health industry.
In addition, at the 83rd China International Medical Device Expo (CMEF) held on October 19, Shandong Xinhua Medical carried heavy-weight products such as high-volume hemodialysis device, large aperture spiral CT, high-energy medical electron linear accelerator and SERIACE cryogenic sterilizer, presenting a high-tech medical feast for the general audience.